Inventor · disambiguated record
Carl-Henrik Heldin
Also filed as: HELDIN CARL-HENRIK
41 granted patents·7 pending applications·723 citations·filing 1990–2012
98Inventor score
Top patents by PatentIndex Score
48 records- 0192US6699843B2Method for treatment of tumors using nucleic acid ligands to PDGFGILEAD SCIENCES INC·Filed 2001·Granted Mar 2, 2004·101 cites·11 claims
- 0292US6605443B1Method for identifying compounds that affect Smad7 bindingLUDWIG INST CANCER RES·Filed 2001·Granted Aug 12, 2003·35 cites·7 claims
- 0387US5229495ASubstantially pure receptor like TGF-β 1 binding molecules and uses thereofLUDWIG INST CANCER RES·Filed 1991·Granted Jul 20, 1993·64 cites·5 claims
- 0486US5326695APlatelet derived growth factor agonistsLUDWIG INST CANCER RES·Filed 1992·Granted Jul 5, 1994·96 cites·8 claims
- 0584US7592428B1Antibodies which bind specifically to activin receptor like kinasesLUDWIG INST CANCER RES·Filed 2003·Granted Sep 22, 2009·7 cites·2 claims
- 0682US7141375B2Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factorGILEAD SCIENCES INC·Filed 2004·Granted Nov 28, 2006·19 cites·10 claims
- 0781US6331621B1Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing theseLUDWIG INST CANCER RES·Filed 2000·Granted Dec 18, 2001·10 cites·10 claims
- 0881US5280109AIsolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2LUDWIG INST CANCER RES·Filed 1992·Granted Jan 18, 1994·44 cites·3 claims
- 0978US6251628B1Isolated nucleic acid molecules encoding Smad7LUDWIG INST CANCER RES·Filed 1998·Granted Jun 26, 2001·31 cites·18 claims
- 1078US5863738AMethods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptidesCREATIVE BIOMOLECULES INC·Filed 1995·Granted Jan 26, 1999·39 cites·3 claims
- 1176US6982319B2Antibodies which bind specifically to activin receptor-like kinasesLUDWIG INST CANCER RES·Filed 2001·Granted Jan 3, 2006·6 cites·2 claims
- 1276US6316217B1Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding sameLUDWIG INST CANCER RES·Filed 1993·Granted Nov 13, 2001·21 cites·22 claims
- 1375US6706687B1Platelet-derived growth factor DLUDWIG INST CANCER RES·Filed 1999·Granted Mar 16, 2004·41 cites·22 claims
- 1475US5219759ARecombinant DNA encoding PDGF A-chain polypeptide and expression vectorsCHIRON CORP·Filed 1990·Granted Jun 15, 1993·47 cites·6 claims
- 1574US5346993AIsolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2LUDWIG INST CANCER RES·Filed 1993·Granted Sep 13, 1994·30 cites·4 claims
- 1673US7148037B2Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2002·Granted Dec 12, 2006·4 cites·12 claims
- 1772US5731200AIsolated nucleic acid encoding receptor-like TGF-β1 binding proteinLUDWIG INST CANCER RES·Filed 1995·Granted Mar 24, 1998·18 cites·8 claims
- 1870US6673570B1Smad associating polypeptidesLUDWIG INST CANCER RES·Filed 2000·Granted Jan 6, 2004·3 cites·20 claims
- 1967US6207814B1Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding themLUDWIG INST CANCER RES·Filed 1999·Granted Mar 27, 2001·15 cites·5 claims
- 2064US7932351B2Activin receptor-like kinase-1 proteins having serine-threonine kinase domainsLUDWIG INST CANCER RES·Filed 2007·Granted Apr 26, 2011·0 cites·9 claims
- 2164US7067260B2Methods of identifying morphogen receptor-binding analogsCURIS INC·Filed 2001·Granted Jun 27, 2006·4 cites·20 claims
- 2264US6368829B1Smad2 phosphorylation and interaction with Smad4LUDWIG INST CANCER RES·Filed 2000·Granted Apr 9, 2002·1 cites·24 claims
- 2362US7723339B2Combination comprising a signal transduction inhibitor and an epothilone derivativeNOVARTIS AG·Filed 2002·Granted May 25, 2010·2 cites·10 claims
- 2460US8080639B2Antibodies which bind specifically to activin receptor like kinase 3MIYAZONO KOHEI·Filed 2007·Granted Dec 20, 2011·0 cites·4 claims
- 2558US2007042413A1Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 2656US8278043B2Methods and materials related to grey allelesANDERSSON LEIF·Filed 2008·Granted Oct 2, 2012·0 cites·22 claims
- 2756US5821075ANucleotide sequences for novel protein tyrosine phosphatasesLUDWIG INST CANCER RES·Filed 1994·Granted Oct 13, 1998·11 cites·12 claims
- 2856US2007021327A1Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factorGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 2954US6271365B1Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding themLUDWIG INST CANCER RES·Filed 1999·Granted Aug 7, 2001·7 cites·26 claims
- 3054US5227302ADNA encoding platelet derived endothelial cell growth factor (PD-ECGF)LUDWIG INST CANCER RES·Filed 1991·Granted Jul 13, 1993·18 cites·11 claims
- 3153US2005233379A1Methods of antagonizing morphogensLUDWIG INST CANCER RES·Filed 2005·Application pending·0 cites
- 3252US5756686APeptides derived from endothelial cell growth factorLUDWIG INST CANCER RES·Filed 1991·Granted May 26, 1998·11 cites·10 claims
- 3350US9096901B2Methods and materials related to hair pigmentation and cancerANDERSSON LEIF·Filed 2012·Granted Aug 4, 2015·0 cites·6 claims
- 3449US6632618B1Morphogenic protein-specific cell surface receptors and uses thereforCURIS INC·Filed 1995·Granted Oct 14, 2003·4 cites·6 claims
- 3549US2002146774A1Smad2 phosphorylation and interaction with Smad4Filed 2002·Application pending·0 cites
- 3647US6974816B2Combination for the treatment of endothelial damageLUDWIG INSTITIUTE FOR CANCER R·Filed 2002·Granted Dec 13, 2005·0 cites·7 claims
- 3747US6103869ASmad2 phosphorylation and interaction with Smad4LUDWIG INST CANCER RES·Filed 1998·Granted Aug 15, 2000·11 cites·16 claims
- 3847US5177197AIsolated nucleotide sequence expressing human transforming growth factor-β1-binding proteinLUDWIG INST CANCER RES·Filed 1990·Granted Jan 5, 1993·10 cites·12 claims
- 3945US2005136043A1TGFbeta signaling inhibitorsLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 4043US6475775B1PARG, a GTPase activating protein which interacts with PTPL1LUDWIG INST CANCER RES·Filed 2000·Granted Nov 5, 2002·0 cites·11 claims
- 4142US2003166232A1PARG, a GTPase activating protein which interacts with PTPL1Filed 2002·Application pending·0 cites
- 4240US2002164687A1Platelet-derived growth factor C, DNA coding therefor, and uses thereofFiled 2001·Application pending·0 cites
- 4339US5444151APlatelet derived growth factor antagonistsLUDWIG INST CANCER RES·Filed 1992·Granted Aug 22, 1995·9 cites·5 claims
- 4436US6066472ANucleic acids coding for GLM-2, a novel protein tyrosine phosphataseLUDWIG INST CANCER RES·Filed 1998·Granted May 23, 2000·3 cites·12 claims
- 4532US5605816ARecombinant DNA encoding PDGF A-chain polypeptidesCHIRON CORP·Filed 1995·Granted Feb 25, 1997·1 cites·13 claims
- 4627US6939849B1Recombinant PDGF A-chain homodimers and methods of useCHIRON CORP·Filed 1995·Granted Sep 6, 2005·0 cites·12 claims
- 4726US9296818B2Cleavage inhibitors of transforming growth factor beta type I receptor and uses thereof in cancer therapyLANDSTROM MARENE INGA-BRITT·Filed 2012·Granted Mar 29, 2016·0 cites·10 claims
- 4826US6083721AIsolated nucleic acid molecules encoding PARG, a GTPase activating protein which interacts with PTPL1LUDWIG INST CANCER RES·Filed 1998·Granted Jul 4, 2000·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Carl-Henrik Heldin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →